Business Wire India
| Prof. Frank Stangnberg-Haverkamp, Chairman of the Executive Board of E.Merck KG and the Chairman of Merck Foundation Board of Trustees, meets the President of Niger H.E. Mahamadou Issoufou to discuss Merck Foundation Commitment towards Niger |
Merck foundation appointed the First Lady of Niger H.E. Mrs. Aissata Issoufou Mahamadou as an Ambassador of 'Merck More Than a Mother'
Cultural dance and music performance during the event in Niger
Merck Foundation underscore their long term commitment to build healthcare capacity in Niger
Merck Foundation, the philanthropic arm of Merck KGaA, meets President of Niger, H.E. MAHAMADOU ISSOUFOU to discuss and underscore their long-term commitment towards healthcare capacity building and improving access to innovative and equitable healthcare solutions in Niger. They also addressed their efforts to provide training and empower women and youth in Niger through their successful programs such as; ‘Merck Cancer Access Program’ and ‘Merck More Than a Mother’ in partnership with the First Lady of Niger H.E. Mrs. Aissata Issoufou Mahamadou.
During the meeting, H.E. Mahamadou Issoufou, the President of Niger, emphasized that the Merck Foundation’s programs are aligned with the National Strategy of Niger where healthcare is essential for the social and economic development of the nation.
Prof. Frank Stangenberg-Haverkamp, Chairman of the Executive Board of E.Merck KG and the Chairman of Merck Foundation Board of Trustees underscored, " We are very proud to launch our Merck Foundation in partnership with the First Lady of Niger and Ministry of Health to build healthcare capacity, improve access to Cancer and Diabetes care and to empower infertile women in the country."
Dr. Rasha Kelej CEO of Merck Foundation explained, “We are very proud to appoint H.E. Mrs. Aissata Issoufou Mahamadou, the First Lady of The Republic of Niger, as the ambassador of ‘Merck More Than a Mother’ campaign, to work closely with Merck Foundation in defining interventions to break the stigma around childless women across the country. Through our partnership, we will transform the lives of the forgotten women, women who suffered all their lives from the infertility stigma in silence. We are not leaving them alone, Merck Foundation will try to change their lives and change the social perception of them through Art, Media, Advocacy, Awareness and all the appropriate tools that can influence society.”
“We witnessed a great deal of creativity from people in Niger addressing this sensitive issue through developing two songs in local and French language and a theatre play, to emphasize the suffering infertile women undergoing every day, and asking the community to break the stigma around infertility. This emphasized the important role art plays to change bad behavior and raise awareness among communities.” Rasha Kelej added.
Moreover, Merck Foundation is committed to providing one-year to two-years Oncology Fellowship Programs and Clinical Fertility Management Training to seven candidates from Niger in 2018 and is determined to provide training to more candidates in the future.
Merck Foundation is committed to contributing toward advancing Diabetes Care in Niger, by providing online Diabetes Management Diploma in the French language, for medical postgraduates in Niger and other Francophone African countries, so that they can learn more about diagnosis and treatment of diabetes. The course is accredited by 'Royal College for general practitioners' in the UK.
Join the conversation on our social media platforms below and let your voice be heard
Website: www.merck-foundation.com
Join Merck Foundation healthcare & research online community to exchange experience and information with other healthcare providers, researchers, students, policy makers and community members in Africa and beyond.
www.merck-foundation.com free registration
About Merck Foundation
The Merck Foundation, established in 2017, is a philanthropic organization that aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please go to www.merck-foundation.com to read more and/or register online to interact and exchange experience with our registered members.
Merck Foundation is a subsidiary of Merck KGaA Germany
About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
This is unedited, unformatted feed from Business wire india.